LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer

Por Zhang, Yuanyuan, Yang, Rui, Lian, Jianchun, Xu, Haiyan
Publicado no Am J Transl Res (2016)

AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer

Por Papathanasiou, Maria, Lambaki, Sofia, Porpodis, Konstantinos, Spyratos, Dionysios, Tryfon, Stayros, Zarogoulidis, Paulos, Eleytheriadoy, Ellada, Kontakiotis, Theodoros
Publicado no Ann Transl Med (2016)

Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1 ≥50%

Por Zarogoulidis, Paul, Papadopoulos, Vasilis, Maragouli, Elena, Papatsibas, George, Sardeli, Chrysanthi, Man, Yan-Gao, Bai, Chong, Huang, Haidong
Publicado no Transl Lung Cancer Res (2018)

Asbestos-induced lung diseases: an update

Por KAMP, DAVID W.
Publicado em 2009

AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and protecting blood-brain barrier

Por Li, Hongru, Chen, Yusheng, Xu, Nengluan, Yu, Meie, Tu, Xunwei, Chen, Zhengwei, Lin, Ming, Xie, Baosong, Fu, Jianjun, Han, Lili
Publicado no Am J Transl Res (2017)

Whacking a mole-cule: clinical activity and mechanisms of resistance to third generation EGFR inhibitors in EGFR mutated lung cancers with EGFR-T790M

Por Costa, Daniel B., Kobayashi, Susumu S.
Publicado no Transl Lung Cancer Res (2015)

MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer

Por Gong, Fangchao, Ren, Ping, Zhang, Yan, Jiang, Jindong, Zhang, Hong
Publicado no Am J Transl Res (2016)

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique

Por Nicoś, M., Krawczyk, P., Wojas-Krawczyk, K., Bożyk, A., Jarosz, B., Sawicki, M., Trojanowski, T., Milanowski, J.
Publicado no Clin Transl Oncol (2017)

Limited resection in clinical stage I non-small cell lung cancer patients aged 75 years old or more: a meta-analysis

Por Zhang, Zhenrong, Feng, Hongxiang, Xiao, Fei, Liu, Deruo
Publicado no Ann Transl Med (2018)

Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non–Small Cell Lung Cancer

Por Nielsen, Signe Holm, Willumsen, Nicholas, Brix, Susanne, Sun, Shu, Manon-Jensen, Tina, Karsdal, Morten, Genovese, Federica
Publicado no Transl Oncol (2018)

Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

Por Wurz, Gregory T, Gutierrez, Audrey M, Greenberg, Brittany E, Vang, Daniel P, Griffey, Stephen M, Kao, Chiao-Jung, Wolf, Michael, DeGregorio, Michael W
Publicado em 2013

Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastases

Por Zhao, Fengshu, He, Xiangfeng, Sun, Jianan, Wu, Di, Pan, Meng, Li, Miao, Wu, Songyan, Zhang, Rong, Yan, Chunguang, Dou, Jun
Publicado no Am J Transl Res (2015)

Pembrolizumab in advanced pretreated small cell lung cancer patients with PD-L1 expression: data from the KEYNOTE-028 trial: a reason for hope?

Por Navarro, Alejandro, Felip, Enriqueta
Publicado no Transl Lung Cancer Res (2017)

Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer

Por Schuller, Hildegard M.
Publicado no Transl Lung Cancer Res (2018)

Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer

Por Yip, Po Yee
Publicado no Transl Lung Cancer Res (2015)

Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report

Por de las Casas, Clara Mayo, Gonzalez-Cao, Maria, Ramirez, Santiago Viteri, Ariza, Nuria Jordana, Balada, Ariadna, Garzón, Mónica, Teixidó, Cristina, Karachaliou, Niki, Morales-Espinosa, Daniela, Molina-Vila, Miguel Ángel, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2016)

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future

Por Proto, Claudia, Imbimbo, Martina, Gallucci, Rosaria, Brissa, Angela, Signorelli, Diego, Vitali, Milena, Macerelli, Marianna, Corrao, Giulia, Ganzinelli, Monica, Greco, Francesca Gabriella, Garassino, Marina Chiara, Lo Russo, Giuseppe
Publicado no Transl Lung Cancer Res (2016)

Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated...

Por Onesti, Concetta Elisa, Iacono, Daniela, Angelini, Silvia, Lauro, Salvatore, Mazzotta, Marco, Occhipinti, Mario Alberto, Giusti, Raffaele, Marchetti, Paolo
Publicado no Transl Lung Cancer Res (2016)

MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2

Por Xu, Guodong, Shao, Guofeng, Pan, Qiaoling, Sun, Lebo, Zheng, Dawei, Li, Minghui, Li, Ni, Shi, Huoshun, Ni, Yiming
Publicado no Am J Transl Res (2017)

HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects...

Por Sun, Lichun, He, Quanyong, Tsai, Cheguo, Lei, Jun, Chen, Jing, Vienna Makcey, Lily, Coy, David H
Publicado no Am J Transl Res (2018)